Physical reaction and psychological adjustment after discontinuation of Sotolaxib (AMG510)

Sotoracib (AMG510) is a therapeutic hope for patients with KRAS gene-mutated advanced non-small cell lung cancer (NSCLC). The possible physical reactions and psychological changes after drug withdrawal are important issues that every patient and their family members need to understand deeply.

1. Physical reaction

1) Dynamic changes in tumors: When treatment with sotoracib is stopped, the tumors in the patient may regain the opportunity to grow. This does not mean that the treatment has failed, but rather that the drug's effectiveness is gradually waning. Therefore, regular tumor surveillance becomes particularly important in order to detect and respond to possible progression in a timely manner.

2) Subsidence and persistence of side effects: Side effects such as nausea, vomiting, fatigue, etc. that may occur during treatment with sotoraxib may gradually lessen after stopping the drug. However, some side effects may persist and require further medical attention and treatment.

Signs of disease progression: For advanced cancers likeNSCLC, the disease may continue to 3) progress even during treatment. After stopping medication, patients and families need to be more vigilant about new symptoms or worsening of existing symptoms, which may be a sign of disease progression.

2. Psychological adjustment

1) Anxiety in the face of uncertainty: The effective treatment of sotoracib may bring a certain improvement in the quality of life and survival period of patients. However, after stopping the drug, patients may feel anxious and fearful in the face of unknown disease progression and loss of treatment effect.

2) Expectations and concerns about alternative treatments: When sotorasiib is no longer suitable or ineffective, doctors may recommend other treatment options. Patients may be full of expectations and worries about these new treatments, which is a very normal psychological reaction.

In general, the reaction after discontinuation of sotorasiib is multifaceted, including physical changes and psychological adjustment. Faced with these challenges, patients and families need to maintain a positive attitude and work closely with the medical team to develop the best treatment and care plan.